← Browse by Condition
Medical Condition
recurrent prostate cancer
Total Trials
4
Recruiting Now
4
Trial Phases
Phase 1, Phase 2, Phase 2
NCT03067051 Phase 1, Phase 2
Recruiting
Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System
Enrollment
66 pts
Location
United States, Canad...
Sponsor
SpectraCure AB
NCT06378866 Phase 2
Recruiting
Stereotactic Body Radiation Therapy Plus Immediate or Delayed Androgen Receptor Pathway Inhibitor and Androgen Deprivation Therapy or Salvage Radiation Therapy for the Treatment of Prostate Cancer, DIVINE Trial
Enrollment
532 pts
Location
United States
Sponsor
Mayo Clinic
NCT06096870 Phase 2
Recruiting
Enzalutamide and PDS01ADC in PET Positive Recurrent Prostate Cancer (pprPC) Without Testosterone Lowering Therapy
Enrollment
65 pts
Location
United States
Sponsor
National Cancer Institute (NCI...
NCT05304858
Recruiting
Tumor Microenvironment Analysis of Prostate Cancer Metastasis
Enrollment
16 pts
Location
United States
Sponsor
Columbia University